These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 835744)

  • 21. A double-blind evaluation of electroconvulsive therapy in Parkinson's disease with "on-off" phenomena.
    Andersen K; Balldin J; Gottfries CG; Granérus AK; Modigh K; Svennerholm L; Wallin A
    Acta Neurol Scand; 1987 Sep; 76(3):191-9. PubMed ID: 2446463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electroconvulsive Therapy for Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Takamiya A; Seki M; Kudo S; Yoshizaki T; Nakahara J; Mimura M; Kishimoto T
    Mov Disord; 2021 Jan; 36(1):50-58. PubMed ID: 33280168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bitemporal electroconvulsive therapy for depression in a Parkinson disease patient with a deep-brain stimulator.
    Bailine S; Kremen N; Kohen I; Linder H; Schwartz GJ; Mogilner AY; Pourfar M
    J ECT; 2008 Jun; 24(2):171-2. PubMed ID: 18580566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Electric stimulation (ECT) in Parkinson disease].
    Dam H; Pakkenberg H; Bolwig TG
    Ugeskr Laeger; 1992 Jan; 154(4):183-7. PubMed ID: 1736441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electroconvulsive therapy for depression in a Parkinson's disease patient with bilateral subthalamic nucleus deep brain stimulators.
    Chou KL; Hurtig HI; Jaggi JL; Baltuch GH; Pelchat RJ; Weintraub D
    Parkinsonism Relat Disord; 2005 Sep; 11(6):403-6. PubMed ID: 15994113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Parkinson's disease with electroconvulsive therapy.
    Rasmussen K; Abrams R
    Psychiatr Clin North Am; 1991 Dec; 14(4):925-33. PubMed ID: 1771154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Letter to the editor: successful use of electroconvulsive therapy for refractory anxiety in Parkinson's disease.
    Marino L; Friedman JH
    Int J Neurosci; 2013 Jan; 123(1):70-1. PubMed ID: 23038993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electroconvulsive therapy in Parkinson's disease and other movement disorders.
    Faber R; Trimble MR
    Mov Disord; 1991; 6(4):293-303. PubMed ID: 1758447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporary interruption of deep brain stimulation for Parkinson's disease during outpatient electroconvulsive therapy for major depression: a novel treatment strategy.
    Ducharme S; Flaherty AW; Seiner SJ; Dougherty DD; Morales OG
    J Neuropsychiatry Clin Neurosci; 2011; 23(2):194-7. PubMed ID: 21677249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to L-dopa: a pilot study.
    Pintor LP; Valldeoriola F; Fernández-Egea E; Sánchez R; Rami L; Tolosa E; Muñiz A; Martí MJ; Bernardo M
    J ECT; 2012 Jun; 28(2):87-91. PubMed ID: 22531200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and treatment of depression in Parkinson's disease.
    Veazey C; Aki SO; Cook KF; Lai EC; Kunik ME
    J Neuropsychiatry Clin Neurosci; 2005; 17(3):310-23. PubMed ID: 16179652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ECT-induced delirium in depressed patients with Parkinson's disease.
    Figiel GS; Hassen MA; Zorumski C; Krishnan KR; Doraiswamy PM; Jarvis MR; Smith DS
    J Neuropsychiatry Clin Neurosci; 1991; 3(4):405-11. PubMed ID: 1821261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electroconvulsive therapy in parkinsonism with affective disorder.
    Atre-Vaidya N; Jampala VC
    Br J Psychiatry; 1988 Jan; 152():55-8. PubMed ID: 3167408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors for improvement after electroconvulsive therapy in parkinsonian patients with on-off symptoms.
    Balldin J; Granérus AK; Lindstedt G; Modigh K; Wålinder J
    J Neural Transm; 1981; 52(3):199-211. PubMed ID: 7310392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delusional depression in Parkinson's disease.
    Sandyk R
    Int J Neurosci; 1993 May; 70(1-2):69-74. PubMed ID: 8083026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skin Picking Heralding Parkinson's Disease.
    Chee KY; Evans AH; Velakoulis D
    J Neuropsychiatry Clin Neurosci; 2016; 28(2):e23-4. PubMed ID: 27093384
    [No Abstract]   [Full Text] [Related]  

  • 37. Depression and Parkinson's disease: a review.
    Cummings JL
    Am J Psychiatry; 1992 Apr; 149(4):443-54. PubMed ID: 1372794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of depression in Parkinson's disease.
    Sawabini KA; Watts RL
    Parkinsonism Relat Disord; 2004 May; 10 Suppl 1():S37-41. PubMed ID: 15109585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New dopamine agonist pramipexole improves parkinsonism and depression in Parkinson's disease.
    Harada T; Ishizaki F; Horie N; Nitta Y; Yamada T; Sasaki T; Nagakane T; Yasumatsu Y; Nitta K; Katsuoka H
    Hiroshima J Med Sci; 2011 Dec; 60(4):79-82. PubMed ID: 22389951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ECT in Parkinson's disease. Changes in motor symptoms, monoamine metabolites and neuropeptides.
    Fall PA; Ekman R; Granérus AK; Thorell LH; Wålinder J
    J Neural Transm Park Dis Dement Sect; 1995; 10(2-3):129-40. PubMed ID: 9620060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.